Dr. Ramamurthy Lakshmi Bomalapura, currently working as senior resident and oculoplasty consultant at Karnataka Institute of Medical sciences, Hubli, Karnataka. Having completed my MBBS from Vijayanagar Institute of medical sciences, Ballari, Karnataka, She did her masters in Ophthalmology(MS) from Hassan Institute of medical sciences, Karnataka in the year 2017 and stood 10th to the university.She then,went onto complete post doctoral fellowship of 18 months in Orbit, Ocular oncology and Oculoplasty from Aravind eye Hospital and post graduate Institute of Ophthalmology, Coimbatore Tamilnadu. She has also attended a short term basic posting in ophthalmology sub-specialties at Minto eye Hospital and Regional ophthalmology center Bangalore. Currently,She has 9 international publications, with 3 others under process. My research work involves typhoid related retinitis, ocular surface squamous neoplasia, phacoemulsification, thyroid eye disease association with diabetes and pterygium surgical techniques. Having presented papers in various state, regional and national ophthalmic conferences, She has also been an instructor for instruction course lectures in state conference.
Dr Lakshmi B Ramamurthy's special areas of interest includes, Dacryology, lid deformity correction, thyroid related orbital discorders, anophthalmic sockets, uveitis related pathologies, ptosis and so on. She is passionate about teaching Ophthalmology to undergraduate and postgraduates , with a cumulative teaching experience of 3 years. Her passion towards teaching has led me to publish her work on case based learning in comparison with seminar module. She was also supporter for eye donation , having conducted 3 campaigns for eye donation fortnight, creating public awareness about eye donation. An active participant in community ophthalmology endeavours, She has conducted more than 10 eyecamps and also attended more than 30 ophthalmology camps conducted by aravind eye care system. She has been a part of retinoblastoma awareness week where more than 100 survivors of the retinoblastoma participated